Risk Factor Analysis of Morbidity and 90-Day Mortality of Curative Resection in Patients with Stage IIIA-N2 Non-Small Cell Lung Cancer after Induction Concurrent Chemoradiation Therapy

被引:0
作者
Jeong, Ga Hee [1 ]
Lee, Junghee [1 ]
Jeon, Yeong Jeong [1 ]
Park, Seong Yong [1 ]
Kim, Hong Kwan [1 ]
Choi, Yong Soo [1 ]
Kim, Jhingook [1 ]
Shim, Young Mog [1 ]
Cho, Jong Ho [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea
来源
JOURNAL OF CHEST SURGERY | 2024年 / 57卷 / 04期
关键词
Neoadjuvant concurrent chemoradiation therapy; Non-small cell lung carcinoma; Mortality; Risk factor; COMPREHENSIVE GERIATRIC ASSESSMENT; SURGICAL-TREATMENT; PNEUMONECTOMY; COMPLICATIONS; SURGERY; CHEMOTHERAPY;
D O I
10.5090/jcs.23.165
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Major pulmonary resection after neoadjuvant concurrent chemoradiation therapy (nCCRT) is associated with a substantial risk of postoperative complications. This study investigated postoperative complications and associated risk factors to facilitate the selection of suitable surgical candidates following nCCRT in stage IIIA-N2 non-small cell lung cancer (NSCLC). Methods: We conducted a retrospective analysis of patients diagnosed with clinical stage IIIA-N2 NSCLC who underwent surgical resection following nCCRT between 1997 and 2013. Perioperative characteristics and clinical factors associated with morbidity and mortality were analyzed using univariable and multivariable logistic regression. Results: A total of 574 patients underwent major lung resection after induction CCRT. Thirty-day and 90-day postoperative mortality occurred in 8 patients (1.4%) and 41 patients (7.1%), respectively. Acute respiratory distress syndrome (n=6, 4.5%) was the primary cause of in-hospital mortality. Morbidity occurred in 199 patients (34.7%). Multivariable analysis identified significant predictors of morbidity, including patient age exceeding 70 years (odds ratio [OR], 1.8; p=0.04), low body mass index (OR, 2.6; p=0.02), and pneumonectomy (OR, 1.8; p=0.03). Patient age over 70 years (OR,1.8; p=0.02) and pneumonectomy (OR, 3.26; p<0.01) were independent predictors of mortality in the multivariable analysis. Conclusion: In conclusion, the surgical outcomes following nCCRT are less favorable for individuals aged over 70 years or those undergoing pneumonectomy. Special attention is warranted for these patients due to their heightened risks of respiratory complications. In high-risk patients, such as elderly patients with decreased lung function, alternative treatment options like definitive CCRT should be considered instead of surgical resection.
引用
收藏
页码:351 / 359
页数:9
相关论文
共 26 条
  • [1] Ahn YC, 2001, ACTA ONCOL, V40, P588
  • [2] Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
    Albain, Kathy S.
    Swann, R. Suzanne
    Rusch, Valerie W.
    Turrisi, Andrew T., III
    Shepherd, Frances A.
    Smith, Colum
    Chen, Yuhchyau
    Livingston, Robert B.
    Feins, Richard H.
    Gandara, David R.
    Fry, Willard A.
    Darling, Gail
    Johnson, David H.
    Green, Mark R.
    Miller, Robert C.
    Ley, Joanne
    Sause, Willliam T.
    Cox, James D.
    [J]. LANCET, 2009, 374 (9687) : 379 - 386
  • [3] CONCURRENT CISPLATIN/ETOPOSIDE PLUS CHEST RADIOTHERAPY FOLLOWED BY SURGERY FOR STAGES IIIA(N2) AND IIIB NON-SMALL-CELL LUNG-CANCER - MATURE RESULTS OF SOUTHWEST-ONCOLOGY-GROUP PHASE-II STUDY-8805
    ALBAIN, KS
    RUSCH, VW
    CROWLEY, JJ
    RICE, TW
    TURRISI, AT
    WEICK, JK
    LONCHYNA, VA
    PRESANT, CA
    MCKENNA, RJ
    GANDARA, DR
    FOSMIRE, H
    TAYLOR, SA
    STELZER, KJ
    BEASLEY, KR
    LIVINGSTON, RB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) : 1880 - 1892
  • [4] Nutritional Status and Postoperative Outcome After Pneumonectomy for Lung Cancer
    Bagan, Patrick
    Berna, Pascal
    De Dominicis, Florence
    Pereira, Joao Carlos Das Neves
    Mordant, Pierre
    De La Tour, Bertrand
    Le Pimpec-Barthes, Francoise
    Riquet, Marc
    [J]. ANNALS OF THORACIC SURGERY, 2013, 95 (02) : 392 - 396
  • [5] Balducci Lodovico, 2010, Expert Rev Hematol, V3, P675, DOI 10.1586/ehm.10.72
  • [6] Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer
    Birim, Ö
    Kappetein, AP
    Bogers, AJJC
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2005, 28 (05) : 759 - 762
  • [7] PROSPECTIVE ASSESSMENT OF 30-DAY OPERATIVE MORBIDITY FOR SURGICAL RESECTIONS IN LUNG-CANCER
    DESLAURIERS, J
    GINSBERG, RJ
    PIANTADOSI, S
    FOURNIER, B
    [J]. CHEST, 1994, 106 (06) : S329 - S330
  • [8] Postoperative complications in relation with induction therapy for lung cancer
    Doddoli, C
    Thomas, P
    Thirion, X
    Serée, Y
    Giudicelli, R
    Fuentes, P
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2001, 20 (02) : 385 - 390
  • [9] Early complications in surgical treatment of lung cancer: A prospective, multicenter study
    Duque, JL
    Ramos, G
    Castrodeza, J
    Cerezal, J
    Castanedo, M
    Yuste, MG
    Heras, F
    Encuentra, AL
    Porta, RR
    Casanova, J
    Pac, J
    Matilla, JM
    deRota, AF
    Pages, C
    Aragoneses, FG
    Moreno, N
    Freixenet, J
    Roca, J
    Llobregat, N
    Garrido, JA
    Manes, H
    Prim, JMG
    Mateu, M
    Pont, GG
    deNicolas, JLM
    Gamez, P
    Rodriguez, J
    Alvarez, F
    Palencia, AS
    Garcia, AJT
    Gomez, A
    Lanza, JT
    Rivas, JJ
    Simo, GV
    Jimenez, M
    Ugarte, AV
    Cordoba, M
    Pun, YW
    [J]. ANNALS OF THORACIC SURGERY, 1997, 63 (04) : 944 - 950
  • [10] Comprehensive geriatric assessment for older patients with cancer
    Extermann, Martine
    Hurria, Arti
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (14) : 1824 - 1831